We know youre tired of fighting your insurance company just to get a GLP-1
Tirzepatide (Zepbound / Mounjaro) targets both GLP-1 and GIP receptors, offering a dual-action approach that clinical trials show may lead to even greater weight loss
Indo-German Consultancy Services Friedrich-Ebert-Anlage 36 60325 Frankfurt am Main Tel.: +49 69 742 2200 (WhatsApp) Fax.: +49 69 742 220 180 Unsere ffnungszeiten Montag bis Freitag: von 9:00 bis 13:30 Uhr & 14.00 bis 17:30 Uhr Kontoverbindung Deutsche Bank AG Indo German Consultancy Services Ltd
In a series of phase 3 trials (LEAD trials), liraglutide was shown to be more effective in reducing HbA1c by 1.2 to 1.6% when used either as monotherapy or in combination with other diabetes drugs, whilst conferring weight loss of 23 kg, an effect which is especially favourable in comparison to the weight gain associated with insulin glargine or sulphonylurea treatment [18]
They can explore whether there are barriers to adherence that need addressing, such as injection anxiety, side effects, or practical difficulties with the injection device